These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1035 related items for PubMed ID: 27110810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
    Lee GJ, Chu KB, Inn KS, Moon EK, Quan FS.
    Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H, Peng X, Jiao H, Zhao D, Ouyang J.
    Microb Cell Fact; 2015 Aug 05; 14():111. PubMed ID: 26242406
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope.
    Chen S, Zheng D, Li C, Zhang W, Xu W, Liu X, Fang F, Chen Z.
    Biomed Res Int; 2015 Aug 05; 2015():901817. PubMed ID: 25767809
    [Abstract] [Full Text] [Related]

  • 10. Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
    Ren Z, Zhao Y, Liu J, Ji X, Meng L, Wang T, Sun W, Zhang K, Sang X, Yu Z, Li Y, Feng N, Wang H, Yang S, Yang Z, Wang Z, Gao Y, Xia X.
    Vaccine; 2018 Sep 25; 36(40):5990-5998. PubMed ID: 30172635
    [Abstract] [Full Text] [Related]

  • 11. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
    Yoshikawa T, Suzuki Y, Nomoto A, Sata T, Kurata T, Tamura Si.
    Vaccine; 2002 Nov 22; 21(1-2):60-6. PubMed ID: 12443663
    [Abstract] [Full Text] [Related]

  • 12. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E, Mata CP, Gómez-Blanco J, Moreno N, Bárcena J, Blanco E, Rodríguez-Frandsen A, Nieto A, Carrascosa JL, Castón JR.
    J Virol; 2015 Mar 22; 89(5):2563-74. PubMed ID: 25520499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
    Quan FS, Kim MC, Lee BJ, Song JM, Compans RW, Kang SM.
    Virology; 2012 Sep 01; 430(2):127-35. PubMed ID: 22658901
    [Abstract] [Full Text] [Related]

  • 16. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A.
    Vaccine; 2016 Jun 17; 34(29):3371-80. PubMed ID: 27155499
    [Abstract] [Full Text] [Related]

  • 17. Immune Correlates of Protection Induced by Virus-Like Particles Containing 2009 H1N1 Pandemic Influenza HA, NA or M1 Proteins.
    Moon EK, Kang HJ, Chu KB, Lee SH, Lee DH, Soh Y, Quan FS.
    Immunol Invest; 2019 May 17; 48(4):355-366. PubMed ID: 30430891
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 52.